Applicant, as named in the Orange Book

Shilpa

Next listed expiry: Docetaxel on 30 Sep 2033. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Docetaxel · 3 strengths docetaxel	docetaxel	205934	30 Sep 2033	patent
Pemetrexed · 3 strengths pemetrexed disodium	pemetrexed disodium	215179	26 Mar 2035	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Bortezomib bortezomib	bortezomib	212782	open now	no listed protection